Recurrent Malignant Testicular Germ Cell Tumor Completed Phase Trials for Etoposide (DB00773)

IndicationStatusPhase
DBCOND0028803 (Recurrent Malignant Testicular Germ Cell Tumor)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00536601High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid TumorsTreatment